Lv4
480 积分 2024-10-21 加入
The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice
1个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
2个月前
已完结
Efficacy and Safety of Telitacicept in IgA Nephropathy: A Retrospective, Multicenter Study
3个月前
已完结
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
3个月前
已完结
Atrasentan in Patients with IgA Nephropathy
3个月前
已完结
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
3个月前
已完结
Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study
3个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
3个月前
已完结
Dapagliflozin in Patients with Chronic Kidney Disease
3个月前
已完结
皖公网安备34019202002308
